GLP-1 receptor agonists for obesity are effective over the long term when paired with lifestyle interventions, but global accessibility must be improved, the World Health Organization (WHO) concluded.
Share:
GLP-1 receptor agonists for obesity are effective over the long term when paired with lifestyle interventions, but global accessibility must be improved, the World Health Organization (WHO) concluded.
Sign up for PCC’s newsletter to get the latest updates about the PCC, Better Health – NOW and our efforts to build a more effective health care system centered on primary care.